Adverse karyotype subcategories in acute myeloid leukemia display significant differences in mutation composition and transplant-augmented survival
Haematologica
.
2023 Jan 1;108(1):245-249.
doi: 10.3324/haematol.2022.281495.
Authors
Ayalew Tefferi
1
,
Amritpal Singh
2
,
Naseema Gangat
2
,
Aref Al-Kali
2
,
Hassan Alkhateeb
2
,
Mithun Shah
2
,
Mrinal S Patnaik
2
,
Michelle A Elliott
2
,
William J Hogan
2
,
Mark R Litzow
2
,
Alexandra Wolanskyj-Spinner
2
,
Christopher C Hook
2
,
Abhishek Mangaonkar
2
,
David Viswanatha
3
,
Dong Chen
3
,
Animesh Pardanani
2
,
Kebede H Begna
2
,
Rhett P Ketterling
4
Affiliations
1
Divisions of Hematology. tefferi.ayalew@mayo.edu.
2
Divisions of Hematology.
3
Hematopathology, Departments of Medicine and Laboratory Medicine, Mayo Clinic, Rochester, MN.
4
Hematopathology, Departments of Medicine and Laboratory Medicine, Mayo Clinic, Rochester, MN. ketterling.rhett@mayo.edu.
PMID:
36073516
PMCID:
PMC9827171
DOI:
10.3324/haematol.2022.281495
No abstract available
Publication types
Letter
MeSH terms
Humans
Karyotype
Karyotyping
Leukemia, Myeloid, Acute* / genetics
Mutation
Prognosis